The Efficacy of Goal Focused, Non-Pharmacological Treatment for Persons With ADHD/ADD.
Attention-Deficit Hyperactivity Disorder, Unspecified Type
About this trial
This is an interventional treatment trial for Attention-Deficit Hyperactivity Disorder, Unspecified Type
Eligibility Criteria
Inclusion Criteria:
- Diagnosis of Hyperkinetic disorder, ADHD or ADD. Both patients recently diagnosed at DPS and patients previously diagnosed can be included.
- Subjective complaints about executive problems affecting everyday life, operationalized as a score of 60 or above on BRIEF-A or as reported in the inclusion interview.
- Motivation for working with the executive problems in order to increase coping in everyday life.
- Adequate language skills to participate in group discussions without any need for an interpreter.
Exclusion Criteria:
- CNS injury or disease other than hyperkinetic disorder, ADHD or ADD.
- Ongoing substance-abuse.
- Psychopathology that would negatively interfere with participation in the intervention, e.g. ongoing psychosis, present suicidal risk to severe to be treated in an out-patient setting or personality disorders considered to severe to be treated in a group-based out-patient setting.
Sites / Locations
- Akershus University Hospital, DPS Nedre Romerike, Postboks 1000
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Interventioh group
Control Group
The intervention consists of Eight group sessions of two hours duration, focusing on GMT and ADHD. The Group consists of six participants and is directed by one neuropsychologist and one psychologist. Four individual sessions with the neuropsychologist/psychologist directing the Group where the participant is guided through the process of formulating GAS-goals. Bi-weekly Telephone follow up focusing on GAS-goal attainment the thre first months following the Group session phase.
Participants in the Control Group receive TAU. Participation in the study does not influence decisions regarding pharmacological interventions in either of the groups.